About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Single Dose AIDS Drug Introduced in South Africa

by Kathy Jones on April 9, 2013 at 8:05 PM
Font : A-A+

 New Single Dose AIDS Drug Introduced in South Africa

A new single dose anti-AIDS drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day has been introduced by South Africa's health minister.

The three-in-one combination anti-retroviral (ARV) was secured at a record-low price and will cost the state 89 rand a month ($10, eight euros) per patient.

Advertisement

"Before 2010, we were buying the most expensive ARVs in the world. Now we are a country where the ARVs are the cheapest in the world," said Health Minister Aaron Motsoaledi.

"It means we can increase the number of people on treatment," he added during a visit to the township of Ga-Rankuwa, about 35 kilometres (22 miles) northwest of the capital Pretoria.
Advertisement

After years of refusing to roll out ARVs, South Africa now has 1.9 million people on treatment among its 5.6 million HIV-positive population, which is the world's largest.

The new pill will be introduced this month to positive pregnant women and breastfeeding mothers, people co-infected with TB, and to new ARV patients.

Patients already on treatment will be assessed by doctors to start switching later this year.

"You're just going to take it once, and it's just going to be less pill burden," said patient Andrew Mosani.

"People are tired (of) taking many drugs on a day to day basis."

The pill also had fewer side effects and was easy to swallow, he added.

The South African National AIDS Council welcomed the treatment shift, saying it hoped it would encourage patients to stay on treatment.

"This is simplifying the way patients have become used to taking ARV treatment," said the council's CEO Fareed Abdullah.

"We have come a very long way since the advent of anti-retrovirals. At one point, patients used to take up to 16 pills a day," he added.

South Africa once refused to roll out ARVs under former president Thabo Mbeki but now has the largest anti-retroviral (ARV) programme in the world.

The scaling up of treatment has seen the number of pregnant women passing on HIV to their babies brought down to less than three percent.

Life expectancy has also shot up by six years to 60 over the past few years.

Source: AFP
Advertisement

Advertisement
Advertisement

Recommended Readings

Latest AIDS/HIV News

 HIV Antibody Response Raised in Patients With Tuberculosis Disease
A new study has found that the co-localization of tuberculosis disease and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies.
Exploring the Consistent Outcomes of an Antiviral Drug
Specific antiviral drug that is widely used to treat smallpox patients since last summer's outbreak is found to produce similar outcomes regardless of the patient's HIV status.
Why Is STI and HIV Screening Decreased While Positive Test Results Increase?
In susceptible communities because of poverty, and racism, the effects of inadequate STI and HIV screening may be more profound.
Who Is Responsible for the Blunting of AIDS Epidemic?
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Are Countries Missing on HIV Self-Testing?
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Single Dose AIDS Drug Introduced in South Africa Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests